甲状腺偏侧萎缩与甲状腺乳头状癌相关
回顾性分析225例经手术病理证实为甲状腺乳头状癌(PTC)患者的术前CT,35例(16%)见同侧甲状腺实质偏侧萎缩(THA)。伴THA的PTC实性成分强化程度较低(增强CT值114.2±18.2 vs 126.7±31.3 HU,p<0.05;强化变化值60.2±18.1 vs 72.3±31.0 HU,p<0.05),97%伴THA的PTC见瘢痕样胶原,两组预后无显著差异。
要点
- PTC患者术前CT可见同侧甲状腺实质偏侧萎缩(THA),发生率16%(35/225)。
- 伴THA的PTC实性成分强化程度较低:增强CT值114.2±18.2 vs 126.7±31.3 HU(p<0.05)。
- 伴THA的PTC中97%见瘢痕样胶原,可能是强化程度低的病理基础。
核心结论
- THA在PTC患者中偶尔可见,伴THA的PTC实性成分强化程度较低,可能由瘢痕样胶原所致,两组预后无显著差异。
研究设计与样本
- 回顾性研究,纳入225例经手术病理证实为PTC且术前行CT检查的患者,比较伴与不伴THA者的CT表现、总生存和无病生存,并评估病理表现。
关键影像表现/征象
- CT上THA定义为PTC同侧甲状腺实质偏侧萎缩。
- 萎缩的甲状腺实质位于右叶20例(57%),左叶15例(43%)。
- 伴THA的PTC实性成分增强CT值为114.2±18.2 HU,不伴THA者为126.7±31.3 HU(p<0.05)。
- 伴THA的PTC实性成分强化变化值(增强CT减平扫CT)为60.2±18.1 HU,不伴THA者为72.3±31.0 HU(p<0.05)。
诊断标准与关键数值
- THA的CT诊断标准为PTC同侧甲状腺实质偏侧萎缩。
- 伴THA的PTC中97%见瘢痕样胶原,即宽束状少细胞胶原伴明亮嗜酸性透明变性,典型见于瘢痕疙瘩。
临床应用与阅片要点
- 阅片时注意PTC同侧甲状腺实质是否存在偏侧萎缩。
- 对伴THA的PTC,实性成分强化程度可能较低,需结合病理(瘢痕样胶原)理解。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The present study aimed to investigate CT imaging features, pathological findings, and prognosis in patients with thyroid hemiatrophy (THA) associated with papillary thyroid carcinoma (PTC).
METHODS: This retrospective study included 225 patients with histopathologically proven PTC treated by surgical resection who underwent preoperative CT scanning. On CT images, THA was defined as thyroid parenchymal hemiatrophy on the ipsilateral side of PTC. CT findings, overall survival, and disease-free survival were compared between patients with and without THA. Pathological findings were also assessed in PTCs with and without THA.
RESULTS: THA was observed in 35 of 225 (16%) patients with PTC. Atrophic thyroid parenchyma was observed in the right lobe of 20 patients (57%) and in the left lobe of the remaining 15 patients (43%). With respect to the solid components within PTCs, contrast-enhanced CT attenuation (114.2 ± 18.2 vs. 126.7 ± 31.3 HU; p < 0.05) and CT attenuation change for contrast-enhanced CT minus unenhanced CT (60.2 ± 18.1 vs. 72.3 ± 31.0 HU; p < 0.05) were significantly lower in PTCs with THA than in those without THA. Histopathologically, almost all PTCs with THA (97%) had keloid-like collagen, which is broad bundles of hypocellular collagen with bright eosinophilic hyalinization, typically observed in keloid. However, no significant differences were observed in the prognosis between the two groups.
CONCLUSION: THA was occasionally observed in patients with PTC. Weak contrast-enhancement was distinct characteristic of PTC patients with THA, which is probably caused by keloid-like collagen.
引用
- Seko T, Kato H, Ando T, et al. Thyroid hemiatrophy associated with papillary thyroid carcinoma. Neuroradiology. 2024. PMID: 39136714. doi:10.1007/s00234-024-03442-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。